Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: A systematic review and meta-analysis

Internal Medicine Journal

Volumn 40, Issue 9, 2010, Pages 633-641

  Nath, A ^a   Agarwal, R ^a   Malhotra, P ^a,b   Varma, S ^a,b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b Department of Internal Medicine ^*  (India)

Author keywords

hepatitis B virus; meta analysis; non Hodgkin lymphoma

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CITATION ANALYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MEDLINE; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VIRUS CARRIER; VIRUS DETECTION;

CASE-CONTROL STUDIES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LYMPHOMA, NON-HODGKIN; PREVALENCE;

EID: 77956816391     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02060.x     Document Type: Article

References (56)

1. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008 57 : 1 20.
2. de The G. Viruses and human cancers: challenges for preventive strategies. Environ Health Perspect 1995 103 (Suppl 8 269 73.
3. Parsonnet J, Isaacson PG. Bacterial infection and MALT lymphoma. N Engl J Med 2004 350 : 213 15.
4. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003 125 : 1723 32.
5. Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 2004 111 : 1 8.
6. Nowoslawski A, Krawczynski K, Brzosko WJ, Madalinski K. Tissue localization of Australia antigen immune complexes in acute and chronic hepatitis and liver cirrhosis. Am J Pathol 1972 68 : 31 56.
7. Trepo CG, Zucherman AJ, Bird RC, Prince AM. The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol 1974 27 : 863 8.
8. Dejean A, Lugassy C, Zafrani S, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol 1984 65 (Pt 3 651 5.
9. Pasquinelli C, Laure F, Chatenoud L, Beaurin G, Gazengel C, Bismuth H et al. Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. J Hepatol 1986 3 : 95 103.
10. Pontisso P, Poon MC, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in mononuclear blood cells. Br Med J (Clin Res Ed) 1984 288 : 1563 6.
11. Yoffe B, Noonan CA, Melnick JL, Hollinger FB. Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J Infect Dis 1986 153 : 471 7.
12. Galun E, Ilan Y, Livni N, Ketzinel M, Nahor O, Pizov G et al. Hepatitis B virus infection associated with hematopoietic tumors. Am J Pathol 1994 145 : 1001 7.
13. Thung SN, Gerber MA, Klion F, Gilbert H. Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med 1985 145 : 1313 4.
14. Pinto PC, Hu E, Bernstein-Singer M, Pinter-Brown L, Govindarajan S. Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 1990 65 : 878 84.
15. Kumagai K, Takagi T, Nakamura S, Sawada U, Kura Y, Kodama F et al. Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan. Ann Oncol 1997 8 (Suppl 1 107 9.
16. Liang R, Lau GK, Kwong YL. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol 1999 17 : 394 8.
17. Musolino C, Campo S, Pollicino T, Squadrito G, Spatari G, Raimondo G. Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease. Haematologica 1996 81 : 162 4.
18. Persico E, De Renzo A, La Mura V, Bruno S, Masarone M, Torella R et al. Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients. Gut 2007 56 : 1470 1.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959 22 : 719 48.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 7 : 177 88.
21. Martin DO, Austin H. An exact method for meta-analysis of case-control and follow-up studies. Epidemiology 2000 11 : 255 60.
22. Deeks JJ, Higgins JPT, Altman DG. Analysing and presenting results. In : Alderson P, Green S, Higgins JPT, eds. Cochrane Reviewers' Handbook 422 [Updated March 2004].
23. Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials 1986 7 : 267 75.
24. Dear K, Begg C. An approach to assessing publication bias prior to performing a meta-analysis. Stat Sci 1992 7 : 237 45.
25. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 315 : 629 34.
26. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006 25 : 3443 57.
27. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994 50 : 1088 101.
28. Cucuianu A, Patiu M, Duma M, Basarab C, Soritau O, Bojan A et al. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol 1999 107 : 353 6.
29. Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001 16 : 215 9.
30. Kim JH, Bang YJ, Park BJ, Yoo T, Kim CW, Kim TY et al. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res 2002 93 : 471 7.
31. Iwata H, Matsuo K, Takeuchi K, Kishi Y, Murashige N, Kami M. High incidences of malignant lymphoma in patients infected with hepatitis B or hepatitis C virus. Haematologica 2004 89 : 369 70.
32. El-Sayed GM, Mohamed WS, Nouh MA, Moneer MM, El-Mahallawy HA. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients. Egypt J Immunol 2006 13 : 105 14.
33. Marcucci F, Mele A, Spada E, Candido A, Bianco E, Pulsoni A et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. Haematologica 2006 91 : 554 7.
34. Mehdi SR, AlAjlan AR. Hepatitis B & C virus infection in cases of Non-Hodgkin's lymphoma in Saudi Arabia. Turk J Hematol 2006 23 : 200 4.
35. Lim ST, Fei G, Quek R, Lim LC, Lee LH, Yap SP et al. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 2007 79 : 132 7.
36. Sonmez M, Bektas O, Yilmaz M, Durmus A, Akdogan E, Topbas M et al. The relation of lymphoma and hepatitis B virus/hepatitis C virus infections in the region of East Black Sea, Turkey. Tumori 2007 93 : 536 9.
37. Ulcickas Yood M, Quesenberry CP, Guo D, Caldwell C, Wells K, Shan J et al. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 2007 46 : 107 12.
38. Wang F, Xu RH, Han B, Shi YX, Luo HY, Jiang WQ et al. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 2007 109 : 1360 4.
39. Park SC, Jeong SH, Kim J, Han CJ, Kim YC, Choi KS et al. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea. J Med Virol 2008 80 : 960 6.
40. Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 2006 19 : 449 90.
41. Pagano JS. Viruses and lymphomas. N Engl J Med 2002 347 : 78 9.
42. Dai MS, Chao TY, Kao WY, Shyu RY, Liu TM. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP. Ann Hematol 2004 83 : 769 74.
43. Tsutsumi Y, Kanamori H, Mori A, Tanaka J, Asaka M, Imamura M et al. Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Saf 2005 4 : 599 608.
44. Awerkiew S, Daumer M, Reiser M, Wend UC, Pfister H, Kaiser R et al. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. J Clin Virol 2007 38 : 83 6.
45. Targhetta C, Cabras MG, Mamusa AM, Mascia G, Angelucci E. Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy. Haematologica 2008 93 : 951 2.
46. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981 81 : 987 91.
47. Chou CK, Wang LH, Lin HM, Chi CW. Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells. Hepatology 1992 16 : 13 8.
48. Cheng AL. Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma. Blood 1996 87 : 1202.
49. Ng HJ, Lim LC. Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report. Ann Hematol 2001 80 : 549 52.
50. Hernandez JA, Diloy R, Salat D, del Rio N, Martinez X, Castellvi JM. Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab. Haematologica 2003 88 : ECR22.
51. Law JK, Ho JK, Hoskins PJ, Erb SR, Steinbrecher UP, Yoshida EM. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk Lymphoma 2005 46 : 1085 9.
52. Perceau G, Diris N, Estines O, Derancourt C, Levy S, Bernard P. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol 2006 155 : 1053 6.
53. Dillon R, Hirschfield GM, Allison ME, Rege KP. Fatal reactivation of hepatitis B after chemotherapy for lymphoma. BMJ 2008 337 : a423.
54. Lubel JS, Testro AG, Angus PW. Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management. Intern Med J 2007 37 : 705 12.
55. Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F et al. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med 2008 148 : 519 28.
56. Agarwal R, Nath A. Activated protein C in sepsis: down but not out, yet. Crit Care 2006 10 : 416.